Cargando…

Azithromycin to Prevent Pertussis in Household Contacts, Catalonia and Navarre, Spain, 2012–2013

We retrospectively assessed the effectiveness of azithromycin in preventing transmission of pertussis to a patient’s household contacts. We also considered the duration between symptom onset in the primary patient and azithromycin administration. We categorized contacts into 4 groups: those treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Alvarez, Josep, Godoy, Pere, Plans-Rubio, Pedro, Camps, Neus, Carol, Monica, Carmona, Gloria, Solano, Ruben, Rius, Cristina, Minguell, Sofia, Barrabeig, Irene, Sala-Farré, Maria R., Rodriguez, Raquel, Garcia-Cenoz, Manuel, Muñoz-Almagro, Carmen, Dominguez, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588542/
https://www.ncbi.nlm.nih.gov/pubmed/33079034
http://dx.doi.org/10.3201/eid2611.181418
Descripción
Sumario:We retrospectively assessed the effectiveness of azithromycin in preventing transmission of pertussis to a patient’s household contacts. We also considered the duration between symptom onset in the primary patient and azithromycin administration. We categorized contacts into 4 groups: those treated within <7 days, 8–14 days, 15–21 days, and >21 days after illness onset in the primary patient. We studied 476 primary index patients and their 1,975 household contacts, of whom 4.5% were later identified as having pertussis. When contacts started chemoprophylaxis within <21 days after the primary patient’s symptom onset, the treatment was 43.9% effective. Chemoprophylaxis started >14 days after primary patient’s symptom onset was less effective. We recommend that contacts of persons with pertussis begin chemoprophylaxis within <14 days after primary patient’s symptom onset.